Blaze Bioscience Announces Trial in Progress Presentation at ASCO 2016 Annual Meeting.The poster presentation, titled “Phase 1 Dose Escalation and Expansion Safety Study of BLZ-100 in Pediatric Subjects with Primary Central Nervous System Tumors,” will highlight the company’s first study in the pediatric population.
Source:
www.businesswire.com/news/home/20160531005190/en/Blaze-Bioscience-Announces-Trial-Progress-Presentation-ASCO
Source:
www.businesswire.com/news/home/20160531005190/en/Blaze-Bioscience-Announces-Trial-Progress-Presentation-ASCO

